Form D · Biotechnology

MSI METHYLATION SCIENCES, INC.

Burnaby, A1 · CIK 0001424669

Offering snapshot reported Mar 24, 2015 · SEC filing

Reported sold
$19.8K
Offering amount: $19.8K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 19, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 24, 2015Initial$19,783No comparison2SEC filing
Oct 20, 2011Initial$5,645No comparison2SEC filing
Apr 7, 2010Initial$6,800No comparison2SEC filing
Jul 20, 2009Initial$0No comparison1SEC filing
Feb 6, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jan 17, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-236483

Source: Form D, filed Mar 24, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick R. Brady Director
Howard David Director
Christian H. Fibiger Director
Joshua Freedman Promoter
Barry Guld Director, Executive
Nancy Harrison Executive
Jim Heppell Director
David Howard Director
Jay D. Kranzler Director
Karim Lalji Director
David Mac Donald Executive
Steve Targum Executive
Gunnar Weikert Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4475 Wayburne, Suite 108
Burnaby, A1, V5G 4X4